Dilated Cardiomyopathy (DCM) Therapeutics Market Size, Share, Growth, Analysis Report 2028

 

The global dilated cardiomyopathy (DCM) therapeutics market is anticipated to grow with a significant CAGR of 8% during the forecast period. DCM is one of the prevalent causes of heart failure in adult patients and represents the most common diagnosis leading to a heart transplant in children. The advancements in healthcare and the introduction of new modern techniques are reducing the challenges for the treatment of pediatric DCM. In addition to this, better understanding the pathogenesis of pediatric DCM and the development of effective therapies outside of cardiac transplantation is also driving the DCM therapeutics market.

A full report of Dilated Cardiomyopathy (DCM) Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/dilated-cardiomyopathy-dcm-therapeutics-market

Furthermore, stem cell and cell-based therapies are offering an innovative approach to restore cardiac structure and function towards normal in pediatric patients. This is possibly reducing the need for aggressive therapies and cardiac transplantation. Hence, a systematic investigation needs to be done by the medical community which will benefit current and novel treatments for pediatric DCM. For instance, mesenchymal stem cells and cardiac stem cells are found to be the most promising cell types for treating children with dilated cardiomyopathy. Therefore, the increasing research activities for stem cell and cell-based therapies are anticipated to drive the DCM therapeutic market significantly during the forecast period.

To learn more about this report request a sample copy @ https://www.omrglobal.com/industry-reports/dilated-cardiomyopathy-dcm-therapeutics-market

Moreover, the combination of complementary and alternative medicines as adjunctive therapy is also anticipated to benefit DCM patients. For instance, the combination of conventional medical treatment and oral Chinese herbal medicine is representing exciting adjunctive therapies for the DCM. Several of the effective Chinese drugs pharmaceutics for treating DCM includes Huangqi injection, Qiliqiangxin Capsule, and Shenfu injection. This is also anticipated to drive the DCM therapeutics industry share, especially in the Asia-Pacific region. Some of the key players active in the global DCM therapeutics market include Binance, Bitstamp Ltd., Blockstream Corp. Inc., BlockCypher, Inc., Coinbase UK, Ltd., Luno Pte. Ltd., BitMain Technologies Holding Co., and others. By witnessing the opportunity in the market, multiple companies have been successful to secure funding to increase their R&D activities and product portfolio in the DCM therapeutics market.

Global DCM Therapeutics Market- Segmentation

By Drug Class

·         Angiotensin-Converting Enzyme (ACE) Inhibitors

·         Beta-Blockers

·         Aldosterone Antagonists

·         Digitalis

·         Angiotensin II Receptor blockers

·         Anticoagulants

By Therapy Devices

·         Implantable Cardioverter-Defibrillators (ICDs)

·         Biventricular Pacemakers

·         Heart Pumps

Global DCM Therapeutics Market- Segment by Region

North America          

·         United States

·         Canada

Europe

·         Germany

·         United Kingdom

·         France

·         Spain

·         Italy

·         Rest of Europe

Asia-Pacific   

·         China

·         Japan

·         India

·         Rest of Asia-Pacific

Rest of the World

·         Middle East & Africa

·         Latin America

Company Profiles

·         Abbott Laboratories

·         Berlin Cures GmbH

·         Capricor Therapeutics, Inc.

·         Cardiol Therapeutics Inc.

·         Celixir plc

·         CENTOGENE N.V.

·         Heartseed Inc.

·         Medtronic plc

·         Merck & Co., Inc.

·         MyoKardia, Inc.

·         Novartis AG

·         Pfizer Inc.

·         Renovacor, Inc.

·         Sanofi SA

·         Tenaya Therapeutics

·         Vericel Corp.

·         Zecardio Therapeutics SL

·         Zensun (Shanghai) Sci & Tech Co., Ltd.

Reasons to Buying From us –

1.       We cover more than 15 major industries, further segmented into more than 90 sectors.

2.       More than 120 countries are for analysis.

3.       Over 100+ paid data sources mined for investigation.

4.       Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 780-304-0404